On Invalid Date, Illumina (NASDAQ: ILMN) reported Q2 2023 earnings per share (EPS) of -$1.48, up 56.47% year over year. Total Illumina earnings for the quarter were -$234.00 million. In the same quarter last year, Illumina's earnings per share (EPS) was -$3.40.
On Invalid Date, Illumina (NASDAQ: ILMN) reported Q2 2023 revenue of $1.18 billion up 1.2% year over year. In the same quarter last year, Illumina's revenue was $1.16 billion.
What was ILMN's revenue growth in the past year?
As of Q3 2023, Illumina's revenue has grown -4.92% year over year. This is 6.83 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 1.91%. Illumina's revenue in the past year totalled $4.46 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.